Cupid Limited, a prominent player in healthcare products, has announced receiving significant orders from the Central Medical Services Society (CMSS) totaling Rs 16.23 crore for the supply of male condoms. These orders exemplify the company’s vital role in supporting the Government of India’s vision for public health and safe lifestyle practices.

Background on CMSS and the Orders

CMSS, established as a Central Procurement Agency (CPA) by the Cabinet, streamlines drug procurement and distribution for the Department of Health & Family Welfare, Ministry of Health and Family Welfare, Government of India. Cupid Limited has secured two separate orders from CMSS – one worth Rs 9.65 crores and the other for Rs 6.58 crores.

Execution Timeline and Company’s Commitment

The orders are scheduled for execution by April 2024, as stated in the company’s exchange filing on January 8, 2024. Aditya Halwasiya, Managing Director of Cupid Limited, expressed excitement about this significant allocation from the Government of India. He reiterated the company’s dedication to supporting the government’s initiatives aimed at ensuring access to essential health resources for the community.

Cupid Limited’s Future Plans and Alignment with Government’s Vision

Further emphasizing the alignment with the Government of India’s initiatives, Halwasiya highlighted Cupid Limited’s proposed production capacity expansion in the next 18-24 months. This expansion is expected to cater efficiently to future orders from the government, supporting the national initiative to ‘Help India Play Safe’.

Cupid Limited’s orders from CMSS mark a significant stride in the healthcare sector, showcasing the company’s commitment to contributing to public health initiatives and enhancing safe lifestyle practices across India. This collaboration is a testament to the company’s ability to meet large-scale demands and its alignment with the government’s vision for health and well-being.

  Aditya Halwasiya, CMSS, Cupid Limited, India, Male Condoms